Cardio/Pulm Flashcards
Four primary things to look for on PFT and what they mean
FVC - the total amount of air that can be put out
FEV1 - How much air comes out in the first second
FEV1/FVC - amt of air expelled in the first second compared to total volume expelled
PEFR - peak flow (max airflow rate achieved)
What is required for the diagnosis of asthma? What is used for monitoring asthma?
Spirometry (PFT) used for diagnosis
Peak flow is used for monitoring
Asthma treatment
- SABA - emergency relief, albuterol
- ICS - controlling persistent asthma
Exercise-induced asthma management
- SABA 15-30min prior to exercise
Asthma controller medications
- ICS (fluticasone, mometasone, budesonide, beclomethasone, ciclesonide) – preferred controller treatment for persistent asthma. use daily for optimal effect
- ICS/LABA - (budesonide + formoterol, fluticasone + salmeterol, mometasone + formoterol) – should only be used in pts who are not controlled by ICS alone
- Leukotriene receptor antagonists or leukotriene modifiers (montelukast) — allergic rhinitis, often used with ICS
Stepwise process for asthma management
Step 1 - SABA
Step 2 (mild asthma) - low dose ICS
Step 3 (moderate asthma) - low dose ICS + LABA
Step 4 (severe asthma) - medium dose ICS + LABA
Severe asthma exacerbation management
ED treatment
SABA + systemic corticosteroids
Warning signs of impending respiratory arrest
drowsiness or confusion
paradoxical throacoabdominal movement
absence of wheezing
bradycardia
absence of pulsus paradoxes
initial PEF or FEV1 < 25% of personal best/predicted value
What should you get for every asthma exacerbation
peak flow
Clinical findings for emphysema
increased AP diameter, hyper resonance (air trapping)
Clinical findings chronic bronchitis
normal AP diameter, normal percussion (resonance), increased Hct, copious blood tinged mucus
What is the electrolyte triad found in emphysema and chronic bronchitis
hypokalemia, hypochloremia, increased NaHCO3
COPD management
SABA (albuterol), LAMA (tiotropium), or LABA (salmeterol)
COPD exacerbation treatment
O2, bronchodilators (SABA), prednisone
Antibiotics (if increased dyspnea, incr sputum, incr sputum purulence)
NIV (BiPAP)
TB diagnosis and treatment
Latent TB - no symptoms
TB disease - significant cough > 3 weeks, chest pain, hemoptysis or sputum production, weakness/fatigue, weight loss, lack of appetite, chills, fever, night sweats
CXR - cavitary lesion
Treatment - isoniazid (INH), rifampin, ethambutol, pyrazinamide (RIPE)
Diseases caused by S. pneumoniae
COMPS
conjunctivitis
otitis media
meningits
pneumonia
sinusitis
Diseases caused by H. influenzae
COMPS
conjunctivitis
otitis media
meningitis
pneumonia
sinusitis
CAP treatment in persons with no significant comorbidities
doxycycline
azithromycin
amoxicillin
Broad spectrum treatment for HAP
Vancomycin or linezolid
+
Pipercillin tazobactam (Zosyn)
Cefepime
Levofloxacin
Imipenem
Amikacin
** Vancomycin + Pipercillin-tazobactam
VAP initial empiric treatment
3 antibiotics
Vancomycin or linezolid +
Pipericllin-tazobactam (Zosyn)
Cefepime
ceftazadime
imipenem
meropenem
aztreonam +
Levofloxacin
ciprofloxacin
Amikacin
Gentamicin
Polymyxin
** Vancomycin + Pipercillin-tazobactam + Levofloxacin
Etiology/Pathology of pneumothorax
- Traumatic injury
- Spontaneous - COPD, asthma, tall, thin males, marijuana smoking
- air trapping and increased pressure can cause a medistinal shift –> compress the great vessels and heart (tension pneumothorax)
S/s of pneumothorax
acute onset of SOB
tachypnea
pleuritic chest pain
Pneumothorax physical exam findings
- hyper resonance to percussion
- absent breath sounds on injured side
- hypotension
- distended neck veins (late sign)
- tracheal deviation
Pneumothorax diagnostic study of choice
CXR - air in pleural space with absent lung markings
Pneumothorax treatment
- needle decompression - first line therapy
- chest tube for patients with symptoms or >2cm
- tension pneumothorax - emergent needle decompression with 14G or 16G IV in the 2nd ICS MCL followed by chest tube placement
ARDS etiology and pathophysiology
inflammatory lung condition c/b direct or indirect injury to the lungs
Diagnostic and inclusion criteria for ARDS
- bilateral diffuse infiltrates c/b non-cardiogenic pulmonary edema/pulm capillary leak
- PAWP/PCWP < 19 mmHg (no evidence of L arterial HTN)
- PaO2/FiO2 < 200
Goals of ventilation for ARDS
- treat the underlying cause, support oxygenation, CO, ventilation
- optimize lung recovery to prevent lung injury
- PEEP = 5, PaO2 55-80, plateau pressure <30
- check plateau pressure q4h, if > 30 decr VT by 1mL/kg, if < 25 increase VT by 1mL/kg
- pH goal 7.3-7.45 - if pH is low increase RR, if pH is high decrease RR
Hemothorax etiology & pathophysiology
- blood accumulation in pleural space caused by some form of traumatic injury (usually) or injury to adjacent structures
S/s of hemothorax
dyspnea, tachypnea, pleuritic chest pain
physical exam findings for hemothorax
dullness to percussion (fluid accumulation)
decreased breath sounds on injured side
signs of hypovolemic shock
hemothorax diagnostic study of choice
CXR - blood in pleural space (white out)
Treatment for hemothorax
chest tube placement, autotransfusion, open thoracotomy in the presence of uncontrolled bleeding
Pulmonary embolism etiology/pathophysiology
thrombus in the arterial system of the lung preventing effective perfusion (not a ventilation problem)
most commonly d/t DVT, also seen in oncologic patients
signs/symptoms of pulmonary embolism
dyspnea, pleuritic chest pain, cough, hemoptysis